SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cassidy, E. M.
Right arrow Articles by O’Keane, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cassidy, E. M.
Right arrow Articles by O’Keane, V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Acute effects of low-dose interferon-{alpha} on serum cortisol and plasma interleukin-6

Eugene M. Cassidy

Department of Psychiatry, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Eire; Department of Neuropsychiatry, Room 32, Maudsley Hospital, Denmark Hill, London SE5 8AZ, UK; cucass{at}hotmail.com

Diarmuid Manning

Sinead Byrne

Emer Bolger

Frank Murray

Department of Gastroenterology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Eire

Neda Sharifi

Department of Endocrinology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Eire

Eleanor Wallace

Mary Keogan

Department of Immunology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Eire

Veronica O’Keane

Department of Psychiatry, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Eire

Major depression is associated with both hypothalamic-pituitary-adrenal (HPA) axis overactivity and immune system activation. Depression is a common occurrence following interferon (IFN)-{alpha} treatment. While IFN-{alpha} is known to stimulate the HPA axis, little is known about the effects of exogenous IFN-{alpha} in humans on the proinflammatory cytokine interleukin (IL)-6, a marker of immune system activation. This study examined the acute effects of IFN-{alpha} on cortisol and IL-6 release, and the time course of any changes in these variables. Serum cortisol and plasma IL-6 were assessed in healthy volunteers over an 8-h period following 3 million units subcutaneous IFN-{alpha} or placebo using a double-blind, placebo-controlled crossover design. IFN-{alpha} resulted in a significant increase in both cortisol and IL-6. Regular sampling over 8 h did not delineate any sequential effect of the rise in these variables over time. We conclude that IFN-{alpha} acutely stimulates both the HPA axis and proinflammatory cytokine release. The hypothesis that the effect of IFN-{alpha} on the HPA axis is indirect and mediated by IL-6 was not supported by this study. Our findings are nonetheless of relevance to the aetiology of depression following IFN-{alpha}.

Key Words: cytokine • depression • HPA axis • interferon alpha • interleukin-6

Journal of Psychopharmacology, Vol. 16, No. 3, 230-234 (2002)
DOI: 10.1177/026988110201600307


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
A. Camacho and B. Ng
Methylphenidate for {alpha}-interferon induced depression
J Psychopharmacol, September 1, 2006; 20(5): 687 - 689.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
C. Maddock, A. Baita, M. G. Orru, R. Sitzia, A. Costa, E. Muntoni, M. G. Farci, B. Carpiniello, and C. M. Pariante
Psychopharmacological Treatment of Depression, Anxiety, Irritability and Insomnia in Patients Receiving Interferon-{alpha}: a Prospective Case Series and a Discussion of Biological Mechanisms
J Psychopharmacol, March 1, 2004; 18(1): 41 - 46.
[Abstract] [PDF]



Advertisement